COVID-19: NAFDAC approves Pfizer Biotech Vaccine for emergency use authorisation On Kindly Share This Story: The National Agency for Food and Drug Administration and Control (NAFDAC) says it has approved the Pfizer Biotech Vaccine for emergency use authorisation for COVID-19 in Nigeria. Its Director-General, Prof. Mojisola Adeyeye, made this known on Friday in a live/zoom media briefing in Lagos. Adeyeye said: “We have approved Pfizer Biotech Vaccine for possible use in the country. “Our COVID-19 vaccine team must carefully review it to make sure that the science behind it is well understood, and also in accordance with our own regulation.”